The China in-vitro diagnostics market is likely to witness substantial growth in forthcoming years. In-vitro diagnostics are medical devices and accessories used to perform diagnostic tests on various samples, such as urine, tissue, and blood, taken from human body. IVDs provide healthcare professionals with essential information related to pathological or physiological state and congenital abnormality, and help to determine safety and compatibility with potential recipients. In addition, IVDs are used to monitor therapeutic procedures related to cancer and other chronic diseases.
The global non-invasive prenatal testing (NIPT) market is estimated to witness significant growth in the coming years due to growing popularity of non-invasive procedures. Improvement in reimbursement policies and introduction of advanced NIPT products are likely to support market growth. Rising awareness regarding these tests across the globe is also poised to create lucrative opportunities in the future. In present days, obstetricians are extensively suggesting these tests for early diagnostic screening in the first trimester of pregnancy.
Visceral Pain Market Report - Payment Link
Global visceral pain market size was estimated at USD 9.51 billion in 2016 and is expected to witness substantial growth on account of its increasing prevalence.
The global allergy diagnostics and therapeutics market is expected to witness significant growth at a CAGR of over 12% over the forecast period.
Biosensors are identified as analytical equipment that changes a biological reaction into electrical indicator and helps in measuring an extensive range of analytes comprising gases, bacteria, organic compounds and others.
The global RSV diagnostics market was estimated at USD 625 million in 2015. This market is anticipated to propagate at a high CAGR of over 10% from 2016 to 2024.
Global STD diagnostics market is esteemed to grow over USD 100 billion over the forecast period. Increasing awareness towards sexually transmitted diseases (STDs) along with rising government initiatives is expected to drive the market growth in this segment.
The rising prevalence of autoimmune diseases and consequent increase in healthcare expenditure globally are the major factors driving the autoimmune disease diagnostics market. Moreover, the favorable government initiatives in various countries are also a factor leading to the growth of global autoimmune disease diagnostics market. As stated by NIH, autoimmune disease is one of the top ten causes of women deaths.
The increasing market penetration of picture archiving and communication systems (PACS) and electronic medical record (EMR) and the efficiency of point of care diagnostics to provide immediate results are the major factors driving the global point of care diagnostics market. In point of care (POC) diagnosis, the tests are conducted near the site of the patient care. The increasing geriatric population globally is also a factor propelling the point of care (POC) diagnostics market. Moreover, increasing usage of home based point of care devices, increasing government support, expansion of therapeutic horizon and rapidly increasing investments by various healthcare institutes to support new product developments are also the factors driving the point of care diagnostics market.